[1]谭兴容,杨刚毅,李伶,等.Exenatide对胰岛素抵抗大鼠胰岛素敏感性及脂联素、瘦素水平的影响[J].陆军军医大学学报(原第三军医大学学报),2010,32(20):2201-2204.
 Tan Xingrong,Yang Gangyi,Li Ling,et al.Exenatide improves insulin sensitivity of insulin resistant rats by decreasing plasma adiponectin and increasing leptin levels[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(20):2201-2204.
点击复制

Exenatide对胰岛素抵抗大鼠胰岛素敏感性及脂联素、瘦素水平的影响(/HTML )
分享到:

陆军军医大学学报(原第三军医大学学报)[ISSN:1000-5404/CN:51-1095/R]

卷:
32卷
期数:
2010年第20期
页码:
2201-2204
栏目:
论著
出版日期:
2010-10-30

文章信息/Info

Title:
Exenatide improves insulin sensitivity of insulin resistant rats by decreasing plasma adiponectin and increasing leptin levels
作者:
谭兴容杨刚毅李伶王毅方超李生兵李钶
重庆市第九人民医院内分泌科;重庆医科大学附属第二医院内分泌科;重庆医科大学检验系临床生化教研室,教育部实验诊断重点实验室
Author(s):
Tan Xingrong Yang Gangyi Li Ling Wang Yi Fang Chao Li Shengbing Li Ke
Department of Endocrinology, 9th People’s Hospital of Chongqing, Chongqing, 400700; Department of Endocrinology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010; Department of Clinical Biochemistry, Key Laboratory of Clinical Laboratory Diagnosis of Ministry of Education, Faculty of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China
关键词:
Exenatide胰岛素抵抗胰岛素敏感性:脂联素瘦素
Keywords:
exenatide insulin resistanceinsulin sensitivityadiponectinleptin
分类号:
R589;R363.27;R977.6
文献标志码:
A
摘要:
目的   探讨Exenatide对高脂诱导胰岛素抵抗(insulin resistance,IR)大鼠胰岛素敏感性及血浆脂联素、瘦素水平的影响。   方法   将69只清洁级健康雄性(SD)大鼠分为对照组(NC组,n=22), 高脂组(HF组, n=23),Exenatide治疗组(HE组,n=24)。高脂诱导胰岛素抵抗大鼠给予Exenatide 10周后,采用扩展胰岛素钳夹技术测定机体胰岛素敏感性和糖脂代谢,并观察血浆脂联素、瘦素水平的变化。   结果   高脂诱导IR大鼠经Exenatide处理(HE组)后, Lee’s指数、空腹血浆游离脂肪酸(FFA)、甘油三酯(TG)、总胆固醇酯(TC)、低密度脂蛋白(LDL)明显降低(P<0.01),高密度脂蛋白(HDL)明显升高(P<0.01)。同时,HE组血浆脂联素水平明显升高(P<0.01),瘦素水平明显降低(P<0.01)。在钳夹稳态时,高脂组(HF)与对照组(NC)相比,血浆FFA、胰岛素(INS)水平均明显升高(P<0.01),葡萄糖输注率(GIR)、葡萄糖清除率(GRd)明显降低(P<0.01),且胰岛素对肝糖输出(HGP)的抑制作用明显障碍(仅抑制16%)。经Exenatide处理后,血浆FFA、INS水平则明显降低(P<0.01),GRd、GIR明显升高(P<0.01),胰岛素对HGP的抑制作用明显增强(抑制67%)。   结论   Exenatide处理可能通过下调血浆瘦素水平和上调血浆脂联素水平,改善糖脂代谢而使机体胰岛素敏感性增加。
Abstract:
Objective  To investigate the effects of exenatide on the plasma levels of adiponectin (ADI) and leptin (LEP) and on insulin sensitivity in insulin resistant rats induced by high fat diet.    Methods  A total of 69 health male rats were divided into control group (n=22, normal chow), and high fat group (n=23, high fat diet) and exenatide treatment group (n=24, high fat diet with exenatide treatment). All rats were fed with corresponding diet for 20 weeks. Insulin resistance was found in 2 later groups after 10 weeks’ high fat diet, and then exenatide (2 μg/kg, ip, twice a day) or normal saline (at same volume and time) were injected for 10 weeks. The insulin sensitivity and glucose lipid metabolism in awaken rats were evaluated by hyperinsulinemic-euglycemic clamp technique combined with 3-[3H] glucose as a tracer. In addition, plasma ADI and leptin levels were measured by ELISA.    Results  Plasma free fatty acids (FFA), triglyceride (TG), total cholesterol (TC),  and low density lipoprotein (LDL) levels were significantly reduced in high fat rats after exenatide treatment (P<0.01), however plasma high density lipoprotein (HDL) level were significantly increased in exenatide treatment group (P<0.01). In addition, plasma leptin levels was also significantly reduced, and plasma ADI levels was significantly increased in exenatide treatment group (P<0.01). During the clamp steady-state, there was a significant increase in plasma FFA and insulin and a significant decrease in glucose infusion rate (GIR), glucose disposal rate (GRd) in high fat group compared to control group (P<0.01). The suppressive effect of insulin on hepatic glucose production (HGP) was significantly blunted (only 16%) in high fat group. In exenatide treatment group, plasma insulin and FFA levels were significantly decreased (P<0.01), GIR and GRd were significantly increased (P<0.01), and HGP was suppressed by 67%.    Conclusion  Exenatide treatment may ameliorate high fat diet-induced insulin resistance by reducing leptin level, elevating adiponectin level and thus improving glucose-lipid metabolism.

相似文献/References:

[1]李亚,李伟,王晶,等.抑郁状态与2型糖尿病形成各阶段代谢指标的相关性分析[J].陆军军医大学学报(原第三军医大学学报),2012,34(16):1697.
[2]陈健,王沛坚,马丽群,等.膳食辣椒素预防高脂饮食诱导的小鼠胰岛素抵抗[J].陆军军医大学学报(原第三军医大学学报),2013,35(07):585.
 Chen Jian,Wang Peijian,Ma Liqun,et al.Dietary capsaicin prevents insulin resistance in high fat diet-induced mice[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(20):585.
[3]马蓉,刘建,伍丽,等.妊娠糖尿病患者胎盘组织脂联素及受体与PPAR-γ和IL-6变化的关系[J].陆军军医大学学报(原第三军医大学学报),2011,33(13):1392.
 Ma Rong,Liu Jian,Wu Li,et al.Relationship of placental adiponectin and its receptors with PPAR-γ and IL-6 in pregnancies with gestational diabetes mellitus[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(20):1392.
[4]金婕,陈静,阎振成.高血压病患者的胰岛素抵抗及咪达普利对其的影响[J].陆军军医大学学报(原第三军医大学学报),2007,29(13):1343.
 JIN Jie,CHEN Jing,YAN Zhen-cheng.Insulin resistance in essential hypertension patients and effect of imidapril on it[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(20):1343.
[5]白晓苏,张素华,丘彦,等.罗格列酮对多囊卵巢综合征患者胰岛素敏感性和β细胞功能之改善[J].陆军军医大学学报(原第三军医大学学报),2006,28(18):1894.
[6]刘红梅,王邦琼,李启富,等.不同糖代谢人群补体C3、超敏C反应蛋白与胰岛素抵抗指数的相关性分析[J].陆军军医大学学报(原第三军医大学学报),2011,33(16):1761.
[7]席瑞霞,舒茂琴,张平.伊贝沙坦对高血压患者内皮舒张功能和自主神经活性的干预效应[J].陆军军医大学学报(原第三军医大学学报),2005,27(07):669.
[8]许官学,石蓓,沈长银,等.胰岛素抵抗在急性心肌梗死患者经皮冠状动脉介入治疗术后再狭窄中的作用[J].陆军军医大学学报(原第三军医大学学报),2010,32(07):725.
[9]吴丹冬,任伟,刘静婧,等.妊娠糖尿病视黄醇结合蛋白4血清水平的研究[J].陆军军医大学学报(原第三军医大学学报),2010,32(17):1894.
[10]庄旭东.肝硬化患者血清脂联素水平与炎性细胞因子和胰岛素抵抗的相关性研究[J].陆军军医大学学报(原第三军医大学学报),2011,33(19):2080.

更新日期/Last Update: 2010-10-19